A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 256
Summary
- Conditions
- Anxiety Disorders
- Generalized Anxiety Disorder
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 7 years and 17 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03924323
- Collaborators
- Not Provided
- Investigators
- Study Director: Leslie Mouldauer, MD Syneos
Get Well Soon